CrushSCI.com
145.8Average days
136.5Median days
119Fastest days
191Longest days
1272025 publications

Paper Review Records

All Paper Review Records

4 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

132 days

Single in situ intratumoral low-dose shikonin hydrogel plus mild photothermal therapy elicits systemic antitumor immunity in immune-cold triple-negative breast cancer

Authors
Tao Pan; Zujian Feng; Ting Shang; Jun Jiang; Fang ZhangShow moreShow less
Affiliations
1. Department of Respiratory and Critical Care Medicine, Xijing Hospital, Air Force Medical University, Xi'an, Shaanxi 710032, P.R. China; 2. Tianjin Key Laboratory of Biomaterial Research, Institute of Biomedical Engineering, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300192, P.R. China; 3. Department of Health Service, Air Force Medical University, Xi'an, Shaanxi 710032, P.R. China; 4. The Second Affiliated Hospital of Xi'an Medical University, Xi'an, Shaanxi 710038, P.R. ChinaShow moreShow less
Official full-text evidence DOI Publisher page
119 days

piR-164552 promotes malignant progression in head and neck squamous cell carcinoma via the RBM4/EIF4E2 signaling axis: Insights from multi-omics and functional analyses

Authors
Shan Yang; Zhen Shang; Shunxian Xia; Hongbo Liu; Yanhan Dong; Xiaomin Wang; Wenhua Xu; Haijun LuShow moreShow less
Affiliations
1. Department of Radiation Oncology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266000, P.R. China; 2. Qingdao Medical College, Qingdao University, Qingdao, Shandong 266071, P.R. China; 3. Institute of Regenerative Medicine and Laboratory Technology Innovation, Qingdao University, Qingdao, Shandong 266071, P.R. China; 4. School of Basic Medicine, Qingdao University, Qingdao, Shandong 266071, P.R. ChinaShow moreShow less
Official full-text evidence DOI Publisher page
191 days

Evaluation of Punicalagin as a multi-targeted therapeutic agent against endometrial cancer

Authors
Zeeshan Ahmad Bhutta; Dohee Ahn; Hong Kyu Lee; Kyung-Chul ChoiShow moreShow less
Affiliations
1. Laboratory of Biochemistry and Immunology, College of Veterinary Medicine, Chungbuk National University, Cheongju, Chungcheongbuk 28644, Republic of Korea; 2. State Key Laboratory of Molecular Vaccinology and Molecular, Diagnostics and Center for Molecular Imaging and Translational Medicine, School of Public Health, Xiamen University, Xiamen, Fujian 361002, P.R. China; 3. Department of Companion Animal Health, College of Biomedical Science and Health, Inje University, Gyeongsangnam 50834, Republic of KoreaShow moreShow less
Official full-text evidence DOI Publisher page
141 days

Triptonide enhances DNA damage by inhibiting TRIP13-mediated DNA repair and synergizes with bortezomib to suppress multiple myeloma

Authors
Fen He; Junjun Li; Lijun Peng; Hongyan Zhao; Maoyou Lu; Ruixin Gao; Siqi Wang; Yu Chen; Ruihan Tang; Zhengguo Li; Linlin Zhang; Xinyu Zhang; Qianhao Li; Weihui Chen; Jiayu Liu; Cong Luo; Xi Zeng; Jiliang XiaShow moreShow less
Affiliations
1. Hunan Province Key Laboratory of Tumor Cellular and Molecular Pathology, Cancer Research Institute, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, P.R. China; 2. Department of Hematology, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, P.R. China; 3. Department of Spine Surgery, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, P.R. ChinaShow moreShow less
Official full-text evidence DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review62 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at [email protected]

Enter your email address so we can reply. Your details will remain private.